Related by context. All words. (Click for frequent words.) 80 Elan Biogen 78 Biogen Idec Elan 75 Arthritis Drug 73 Drug Fails 71 Cholesterol Drug 71 OSI Pharma 70 Epilepsy Drug 70 Anemia Drug 70 Blood Pressure Drug 70 Heartburn Drugs 69 Elan Tysabri 69 Rheumatoid Arthritis Drug 68 Psoriasis Drug 68 Weight Loss Drug 68 Inhaled Insulin 68 Lupus Drug 68 Salix Pharma 68 Lung Cancer Drug 68 Cubist Pharma 68 Prostate Cancer Vaccine 68 Schizophrenia Drug 68 Vertex hepatitis C 67 Genentech Biogen 67 Drug Makers 67 Generic Versions 67 Inspire Pharma 67 Optimer Pharma 67 Cholesterol Lowering Drug 67 Acorda Therapeutics ACOR 67 Arthritis Drugs 67 Drug Maker 67 Gout Drug 67 Anemia Drugs 67 Vanda Pharma 66 FDA Panel Recommends 66 Amylin Pharma 66 Cholesterol Drugs 66 Migraine Drug 66 Osteoporosis Drug 66 Drug Shows Promise 66 BioMarin Pharma 66 Vioxx Successor 66 Generic Lovenox 66 Blood Thinner 66 Onyx Pharma 66 Vertex Pharma 65 Biogen Genentech 65 PDUFA Date 65 AstraZeneca Iressa 64 Generic Version 64 Bayer Onyx 64 Generic Protonix 64 Roche Actemra 64 Submits NDA 64 Statin Drugs 64 Liver Damage 64 Drug Combo 64 Treatment Shows Promise 63 Encysive Pharma 63 Isis Pharma 63 Stronger Warnings 63 Patent Ruling 63 Backs FY# View 63 Generic Version Of 63 Regeneron Pharma 63 Risperidone Oral Solution 63 Combo Therapy 63 Data Suggest 63 Xenoport 63 NRMX 63 FDA Approves Generic 63 Biogen Tysabri 63 Acne Drug 63 Shows Efficacy 63 Revises FY# Outlook 63 Backs FY# Outlook 63 KV Pharma 63 Synta Pharma 62 Febuxostat 62 Oral Laquinimod 62 Drug Approvals 62 FDA Accepts 62 Auxilium Pharma 62 FDA Okays 62 Cyclacel Pharmaceuticals 62 Poniard Pharmaceuticals PARD 62 Momenta Pharma 62 MAP Pharma 62 AMAG Pharma 62 Teva Pharma 62 Osteoporosis Drugs 62 Initiates Phase III 62 Completes Patient Enrollment 62 ImClone Erbitux 62 Receives Approvable Letter 62 Cell Therapeutics CTIC 62 FDA Approvals 62 Seattle Genetics SGEN 62 Supplemental Biologics License Application 62 Lifts FY# View 62 Vertex VRTX 62 Files IND 62 Antidepressant Drug 62 Advisers Urge 62 AM Vitals 62 Drug Coated Stents 62 Metabasis Therapeutics 61 VIVUS VVUS 61 Backs FY# Forecast 61 Stock Plunges 61 Roche Avastin 61 Improves Survival 61 Liver Toxicity 61 Investigational Compound 61 Alexion Pharma 61 Anti Clotting Drug 61 Valeant Pharma 61 Cold Medicines 61 Sunesis Pharma 61 Penwest Pharma 61 Nicotine Vaccine 61 Ample Supply 61 Shingles Vaccine 61 Biotech Firm 61 Romiplostim 61 Amylin AMLN 61 Drugmaker 61 Trubion Pharmaceuticals TRBN 61 Refile 61 Advanced Melanoma 61 Kiacta 61 NPS Pharma 61 Mylan Receives Approval 61 Premarket Movers 61 Trial Halted 61 Warning Label 61 Rotavirus Vaccine 61 Meets Primary Endpoint 61 Novartis Femara 61 Slow Progression 61 Loss Shrinks 61 Biogen BIIB 61 Genetic Mutation 61 Expanded Indication 61 Counter Cholesterol 61 Heart Stents 61 Diet Pill 61 Eurand NV EURX 61 Lowers FY# Outlook 61 Contaminated Heparin 61 Drug Candidate 61 Angiotech Pharma 61 Idenix Pharma 61 Achieves Primary Endpoint 60 Shire plc SHPGY 60 XenoPort XNPT 60 Alnylam Pharma 60 Lilly Cymbalta 60 Results Disappoint 60 BIOTECH STOCKS 60 Genetically Modified Salmon 60 Alexza Pharma 60 Savient Pharmaceuticals SVNT 60 FDA Cracks Down 60 CV Therapeutics CVTX 60 Arena Pharmaceuticals ARNA 60 Urine Test 60 SciClone Pharma 60 CHMP Opinion 60 Icagen ICGN 60 Diamyd Medical Diamyd 60 Idenix Pharmaceuticals IDIX 60 @ FiercePharma 60 Earnings Surge 60 Wyeth Progenics 60 Shows Promise Against 60 Receives Milestone Payment 60 Medivation MDVN 60 Gets FDA Clearance 60 Array BioPharma ARRY 60 Disease Modifying 60 Genetic Tests 60 Therapy Reduces 60 Affymax AFFY 60 GW Pharma 60 Par Pharma 60 Clinical Trial Data 60 Glaxo Avandia 60 Teva Pharm 60 Adventrx 60 FY# EPS Forecast 60 Inc. Endures Analyst 60 Imported Drugs 60 Human Genome lupus 60 Hepatitis B Vaccine 60 Antipsychotic Drug 60 Transition Therapeutics 60 Amylin Pharmaceuticals AMLN 59 Blood Thinning 59 Initiates Enrollment 59 DOV Pharmaceutical 59 Allos Therapeutics ALTH 59 Phase 2b Clinical Trial 59 OSI Tarceva 59 Initiates Clinical Trial 59 Amgen Nplate 59 FDA Approves Drug 59 Combination REOLYSIN R 59 Fungal Infections 59 Paliperidone Palmitate 59 Myeloma Patients 59 Phase 2a Trial 59 Appears Safe 59 OSI Pharmaceuticals OSIP 59 Phase IIa Clinical Trial 59 Defends Itself 59 Device Maker 59 Merck KGaA Erbitux 59 Demonstrates Significant 59 NASDAQ ONXX 59 TransVax 59 Celgene Thalomid 59 Aftermarket Movers 59 PharmaVitae Profile 59 Plans Job Cuts 59 Generic Zocor 59 Neurocrine Biosciences NBIX 59 Brentuximab Vedotin SGN 59 Sanofi Acomplia 59 Showed Significant 59 Unsolicited Tender Offer 59 Outlook Disappoints 59 Cholesterol Lowering 59 Teva Provides Update 59 Ephedra Ban 59 Impax Labs 59 Upside Surprise 59 NDA Submission 59 Glatiramer Acetate 59 Erectile Dysfunction Drug 59 NGSX 59 Adjuvant Treatment 59 Earnings Disappoint 59 Amgen Prolia 59 Initiates Clinical 59 Oral Compound 59 Often Misdiagnosed 59 Treated Patients 59 Stock Tumbles 59 SPRYCEL ® 59 Spectrum Pharmaceuticals SPPI 59 Anti Psychotic Drugs 59 IND Application 59 Clinical Trials Review 59 Medivation Inc 59 Severe Sepsis 59 Potentially Fatal 59 Cigarette Makers 59 UCB Keppra 59 Patent Expirations 59 Initiate Phase 59 Licenses Novel 59 Cervical Cancer Vaccine 59 Receives Orphan Drug Designation 59 IND Filing 59 Inc QLTI 59 Clinical Trial Results 59 MLNM 59 Phase 2b Trial 59 Improved Survival 59 Momenta Pharmaceuticals MNTA 59 Curagen 59 Transplant Patients 59 Trims Loss 59 Sleeping Pill 59 Healthbeat Report 59 @ FierceBiotech 58 PHRM 58 ONXX 58 Profit Beats Expectations 58 FY# Guidance 58 Nymox Pharmaceutical 58 Matches Expectations 58 Kynapid 58 Neose Technologies 58 Therapeutic Competitors companiesandmarkets.com adEgemonye 58 Combination Treatment 58 Stedesa 58 Long Term Efficacy 58 Plaque Psoriasis 58 Regain Footing 58 Mylan Labs 58 Takeda Pharma 58 KB Home Swings 58 Testosterone Patch 58 Anadys Pharma 58 AGI Therapeutics 58 Initiates Phase 2b 58 Hormone Refractory Prostate Cancer 58 Serono SRA 58 Receives Tentative FDA 58 Epilepsy Drugs 58 Endo Pharmaceuticals ENDP 58 InterMune ITMN 58 Alkermes ALKS 58 Vicriviroc 58 Orphan Status 58 Fewer Side Effects 58 Biomarin 58 Biogen IDEC 58 lifts FY# EPS 58 Deaths Linked 58 Shows Promising 58 DVAX 58 gets USFDA nod 58 Bone Fracture 58 BIIB BIIB 58 Treat Heart Failure 58 TSRX 58 Bird Flu Vaccine 58 Proton Pump Inhibitor 58 UCB Cimzia 58 Bristol Myers BMY 58 Gene Linked 58 Oral Cladribine 58 Swine Flu Vaccines 58 Transkaryotic Therapies TKTX 58 Subprime Worries 58 Genentech Provides Update 58 Pivotal Clinical Trial 58 TOP SITES 58 Postmenopausal hormone therapy 58 Genzyme Isis 58 Somaxon Pharmaceuticals 58 GSK Avandia 58 BioMarin BMRN 58 Drug Prevents 58 ADR REPORT 58 POZN 58 Misses Consensus 58 Anti Nausea 58 Migenix 58 Antipsychotic Drugs 58 Survival Benefit 58 Peregrine Pharma 58 nN# * 58 Forest Labs FRX 58 Tentative Approval 58 Helps Determine 58 Phase III Trial 58 MBRX 58 Confirmatory Phase 58 Glufosfamide 58 Corporation GENZ 58 Boosts Outlook 58 Resubmission 58 Indevus Pharma 58 ZymoGenetics ZGEN 58 Abortion Pill 58 AUXL 58 Serious Side Effects 58 Ocrelizumab 58 Granted Orphan Drug 58 Forest Laboratories FRX 58 Demonstrates Positive 58 Effectively Treats 58 Present Preclinical Data 58 Slows Progression 58 COVIDIEN 58 Generic Plavix 58 Daiichi Sankyo Eli Lilly 58 Intravenous Formulation 58 Hepatitis Outbreak 58 Pain Medications 58 ALTH 58 Targacept TRGT 58 Mg Usa 58 Gene Variant 58 Javelin Pharmaceuticals 58 LSE SHP.L 58 Pharmion PHRM 58 Disease Modification 58 TTHI 58 Quick Facts2 58 Cocaine Addiction 58 Clinical Trial Enrollment 58 Corp Plc ELN.I 58 Smallpox Vaccine 58 S#.# [006] 58 Bifeprunox 58 BioSante Pharmaceuticals Reports 58 Sunesis Pharmaceuticals 58 Mercury Fillings 58 Regeneron Pharmaceuticals REGN 58 Gene Variation 58 Nektar Therapeutics NKTR 58 Blood Pressure Drugs 58 Pfizer inhaled insulin 58 Amgen Vectibix 58 Ariad Pharma 58 Citi Downgrades 58 Pegloticase 58 Inc. NASDAQ ITMN 58 Dendreon Provenge 57 Posts 1Q Profit 57 BPAX 57 Settle Probe 57 Botulism Poisoning 57 developer Antisoma plc 57 Salix Pharmaceuticals Ltd 57 Phase IIb Trial 57 BIIB.O Quote Profile Research 57 Teva Pharmaceutical TEVA 57 Biologic License Application 57 Diagnostic Criteria 57 Bret Michaels Condition 57 Novartis Gilenia 57 OSI Pharmaceutical 57 Hedgehog Pathway 57 CRTX 57 Acorda Therapeutics Inc 57 Newly Diagnosed Patients 57 Guides FY# Earnings 57 Dose Escalation 57 Investigational Treatment 57 Impax Laboratories IPXL 57 Shares Plummet 57 Treatment Naïve 57 Xenoport Inc. 57 Wider Than Expected 57 ELN.N 57 GILD GILD 57 Premarket 57 Blood Clot Risk 57 Canvaxin 57 Citi Initiates Coverage 57 Pregabalin 57 Impotence Drug 57 Initiates Clinical Trials 57 Desvenlafaxine Succinate 57 ADHD Medication 57 Traders Pare Bets 57 Cephalon CEPH 57 Rheumatoid Arthritis Patients 57 Guidance Disappoints 57 Shrs Fall 57 Antitrust Lawsuit 57 Praecis 57 Panel Votes 57 Bird Flu Vaccines 57 GTOP 57 Sepracor SEPR 57 Sector Snap Homebuilders 57 Aryx Therapeutics 57 Liver Failure 57 Lowers Risk 57 blood thinner prasugrel 57 Neuvenge 57 Elan ELN 57 Revenue Climbs 57 Asthma Treatment 57 Diabetic Foot Ulcer 57 Futures Slip 57 Anti infective 57 TRACON Pharmaceuticals 57 Shareholder Lawsuits 57 Lifts Dividend 57 Could Predict 57 Biomarker Study 57 RhuDex 57 Q1 Profit Soars 57 Arranon 57 Vitrasert R 57 BioDelivery Sciences 57 Initiate Clinical Trial 57 Cerezyme Fabrazyme Myozyme Aldurazyme 57 authority Gurian Sherman 57 Pfizer Sutent 57 Patients Treated With 57 ARQL 57 Device Makers 57 CTRX 57 Stocks Seesaw 57 Piper Jaffray Initiates Coverage 57 Transdermal Patch 57 Helps Smokers Quit 57 Dendreon prostate cancer 57 Stocks Rise Moderately 57 Effectively Treat 57 ViroPharma VPHM 57 Protalix BioTherapeutics 57 FDA Warns 57 Wyeth Enbrel 57 Long Term Survival 57 Breast Cancer Recurrence 57 GlaxoSmithKline Imitrex 57 Therapy Improves 57 LSE ASM 57 Keryx Biopharma 57 Amgen Enbrel 57 MDVN 57 Bird Flu Pandemic 57 Eli Lilly Zyprexa 57 Sanctura XR 57 Fingolimod 57 Muraglitazar 57 Vanda Pharmaceuticals Inc 57 Gralise 57 Genelabs Technologies 57 Somatuline Autogel 57 Birth Defect Risk 57 Seasonal Flu Vaccine 57 TiVo Posts Narrower 57 Celgene Revlimid 57 Above Consensus 57 Taranabant 57 Protein Linked 57 HCV Protease Inhibitor 57 EYET 57 Newly Diagnosed Multiple Myeloma 57 Approvable 57 Drug Resistant 57 Guides FY# EPS 57 Rat Poison Found 57 Lupus Nephritis 57 Shareholder Lawsuit 57 NICE Recommends 57 Ramelteon 57 Ltd Therapeutic Competitors 57 BioCryst Pharma 57 CLDX 57 Stakeholder Insight 57 Capsules CII 57 Amylin Alkermes 57 Successfully Completes Phase 57 STELARA TM 57 Novel Oral 57 FDA Approvable Letter 57 Humira adalimumab 57 Rigel Pharmaceuticals RIGL 57 Reaffirms Outlook 57 Posts Modest 57 Has Resumed 57 Accentia Biopharmaceuticals 57 Injection Site 57 Genzyme Sanofi 57 Vical VICL 57 IDIX 57 midstage clinical 57 Transcept Pharma 57 Announce Collaboration Agreement 57 Improves Outcomes 57 VPHM 57 Onyx Pharmaceuticals Inc 57 ISPH 57 DepoMed 57 Cladribine 57 Entry Inhibitor 57 Merck Arcoxia 57 Aflibercept 57 Pazopanib 57 Treat Anemia 57 Mabthera 57 Inc AMGN AMGN 57 Yen Rallies 56 Help Smokers Quit 56 Backs FY# 56 Marketing Authorisation Application 56 Silicone Breast Implants 56 Files Investigational 56 RESEARCH ALERT Jefferies 56 Alexion Pharmaceuticals ALXN 56 SCLN 56 Levels Linked 56 AMAG Pharmaceuticals AMAG 56 Partnering Agreements 56 Mylan MYL 56 Savient Pharma 56 United Therapeutics UTHR 56 Abuse Resistant 56 Drags Down 56 Kidney Transplant Patients 56 Bosutinib 56 Orexigen Contrave 56 Brain Scans 56 Sanofi Genzyme 56 Silicone Implants 56 Biogen 56 PF # [002] 56 pulls Darvon painkiller 56 Posts 2Q Loss 56 Dendreon DNDN 56 Montelukast 56 Beats Forecast 56 HER2 Positive Breast Cancer 56 Sales Disappoint 56 Phase III Clinical Trial 56 NYSE WYE 56 Novel Antibiotic 56 FY# EPS Outlook 56 Co BMY 56 STREET LIFE 56 Shows Modest 56 1Q Profit Slips 56 Updates FY# EPS 56 Toremifene 56 RealMoney Radio Mailbag 56 MyVax 56 Vioxx Suits 56 Tanezumab 56 Weight Loss Pill 56 Misses Expectations 56 ResMed RMD 56 Enlarged Prostate 56 Pivotal Phase III 56 Iloperidone 56 Sanofi NYSE SNY 56 Guides Q4 56 Pivotal Trial 56 Pain Relievers 56 Flu Shot Shortage 56 AVASTIN 56 Celgene CELG 56 #k Clearance 56 Accelerated Approval 56 Sentiment Snapshot 56 Savient Pharmaceuticals 56 Antitrust Probe 56 Q1 Adj 56 Rigel Pharmaceuticals 56 Migraine Treatment 56 Below Consensus 56 Guides Q3 56 Alnylam Nasdaq ALNY 56 Hepatitis C Treatment 56 Genes Linked 56 Probing Possible 56 Inc. NASDAQ AMGN 56 Vion Pharmaceuticals 56 TKPHF 56 Loses Momentum 56 Gene Variants 56 Anti Tumor 56 Lowers Outlook 56 Delta Reports Narrower 56 Therapeutic Competitors Companies 56 OPTR 56 1Q Profit Dips 56 Inhibitex INHX 56 ANTEGREN 56 LGND 56 Raptiva efalizumab 56 Drop Sharply 56 Share Buyback 56 Ixempra 56 Corporation GENZ GENZ 56 Topiramate Tablets 56 Muscle Wasting 56 Biogen Avonex 56 Forecast Disappoints 56 Idenix Pharmaceuticals 56 Mulls Sale 56 Renal Cancer 56 Metabolic Disorder 56 Acta Scandinavica 56 Tops Expectations 56 ONGLYZA TM 56 Pirfenidone 56 ZGEN 56 Sniffing Out 56 Misses Views 56 Ligand Pharma 56 Edges Higher 56 Amgen Neulasta R 56 Acadia Pharmaceuticals ACAD 56 Viagra Soft Cialis Soft 56 NASDAQ BIIB 56 Risk Warning 56 Gets Favorable 56 Consensus Estimates 56 Lifts FY# Earnings 56 Safinamide 56 Zenapax 56 Package Insert 56 GOOG AAPL 56 Q3 Profit Plunges 56 Immune Cells 56 R lenalidomide 56 PDL Biopharma 56 Reports Narrower 56 INCY 56 Clinical Guideline 56 Prolongs Survival 56 Calcium Supplements 56 Vpriv 56 QLTI 56 PlayBook Tablet 56 Cell Therapeutics Inc 56 UBS Maintains Buy 56 Subgroup Analysis 56 Prostate Cancer Patients 56 ViroPharma Nasdaq VPHM 56 Merck Schering 56 Patient Treated 56 Guides Q2 56 Autoimmune Disorders 56 Diabetic Nephropathy 56 Genentech Roche 56 Nears Settlement 56 Progressive Multifocal Leukoencephalopathy 56 Schizophrenia Treatment 56 Guidelines Recommend 56 Celgene NASDAQ CELG 56 Receives Orphan Drug 56 Panel Weighs 56 Adentri 56 Exploit Code 56 XTL Biopharmaceuticals 56 Ariad Pharmaceuticals ARIA 56 Calcium Vitamin D 56 Receives Favorable 56 Smallpox Shots 56 Sees Weaker 56 Alemtuzumab 56 Atypical Antipsychotics 56 Patient Enrolment 56 supplemental biologics 56 DYAX 56 Therapy Shows Promise 56 Virus Linked 56 Seen Posting 56 Hikes Dividend 56 Presents Positive 56 Improve Survival 56 AMAG Pharmaceuticals 56 Q4 Profit Plunges 56 Guidelines Issued 56 Immunomedics Announces 56 Strongly Linked 56 Genitope 56 Treatable 56 Vivus VVUS 56 Seen Flat 56 Inflammatory Arthritis 56 Protalix BioTherapeutics PLX 56 GLAXOSMITHKLINE 56 Guides Q1 56 Myogen MYOG 56 Profit Little Changed 56 Isis Pharmaceuticals ISIS 56 OGXI 56 Desvenlafaxine 56 Novartis Prexige 56 Nasdaq SLXP 56 Preterm Labor 56 Shareholder Suit 56 Profit Disappoints 56 Noriega Extradition 56 ImmuPharma 56 Eyetech Pharmaceuticals Inc. 56 Malpractice Suit 56 Sinus Infections 56 As Investors Await 56 LSE PFZ 56 Rising Sharply 56 Credit Woes 56 Restates Earnings 56 Antidepressants Linked 56 Genentech Roche Chugai 55 Presents Preclinical 55 Help Predict 55 Par Pharmaceutical PRX 55 Analyst Predicts 55 Terminally Ill Patients 55 Maintains FY# 55 Begins Clinical Trial 55 Affirms FY# 55 Amicus Therapeutics Inc 55 Glaxo Cervarix 55 Acorda Therapeutics Nasdaq ACOR 55 Cefzil 55 Guides FY# 55 RPRX 55 Unanimously Recommends Approval 55 Shares Slump 55 Idenix Pharmaceuticals Inc. 55 BioMarin Pharmaceutical 55 Reverses Loss 55 Reduces Mortality 55 Nabi HB Intravenous 55 Back Pain Sufferers 55 Biogen Idec Tysabri 55 Onyx Pharmaceuticals ONXX 55 MDCO 55 Trims Losses 55 Proton Pump Inhibitors 55 Anticancer Drug 55 Exec Resigns 55 GlaxoSmithKline Lamictal 55 Cautious Outlook 55 Oxcarbazepine 55 Human Genome Sciences HGSI 55 Ziopharm 55 Profit Fell 55 Vaccine Makers 55 Sees Upside 55 Magnetic Stimulation 55 Lorus Therapeutics 55 Ambrisentan 55 Gets Subpoena 55 Ambrilia Biopharma 55 1Q Loss Widens 55 Hematide ™ peginesatide 55 Stocks Pare Losses 55 Demonstrates Potent 55 Genetic Variations 55 Profit Leaps 55 Phase 2a Clinical Trial 55 drug Treanda 55 Narrows 2Q 55 Tysabri natalizumab 55 Immunosuppressant 55 Stomach Cancer 55 Votes Unanimously 55 Seasonal Influenza Vaccine 55 Losses Widen 55 Completes Enrollment 55 Investors Await 55 Suit Vs 55 Stocks Sag 55 Bipolar Depression 55 Own Stem Cells 55 Carrols Restaurant 55 Celldex Therapeutics CLDX 55 Investors Await Fed 55 Genzyme GENZ 55 4Q Profit Soars 55 Anti Inflammatory Drug 55 Subprime Woes 55 Remains Flat 55 Asthma Medication 55 Efficacy Results 55 SUTENT ® 55 Theravance THRX 55 Cardiome Pharma 55 Ariad Pharmaceuticals 55 Sector Snap Staffing 55 Seroquel quetiapine 55 Reaffirms FY# 55 Novartis AG Foradil 55 Backs FY# Earnings 55 Nudges Up 55 Boosts FY# EPS 55 Stocks Narrowly Mixed 55 Boosts Guidance 55 Tysabri Biogen Idec 55 developer Endo Pharmaceuticals 55 Meets Estimates 55 Lifts FY# Revenue 55 Shire SHPGY 55 CVTX 55 Identifies Potential 55 AstraZeneca AZN.L 行情 55 MannKind MNKD 55 Earnings Soar 55 Weight Loss Supplement 55 Anadys Pharmaceuticals 55 Reduced Risk 55 Drug Pipeline 55 Slowing Growth 55 Could Worsen 55 Rivastigmine 55 Biogen Idec BIIB 55 Profit Dips 55 FDA Warns Against 55 Threshold Pharmaceuticals 55 RESEARCH ALERT Deutsche 55 Cypress Bioscience CYPB 55 Eisai Aricept 55 Amylin Pharmaceuticals Nasdaq AMLN 55 Nasdaq IDIX 55 Dendreon Corp 55 Zegerid OTC 55 Increases Risk 55 Raises PT 55 Profit Beats Forecasts 55 Stocks Rise Modestly 55 Menopausal Women 55 Q2 Profit Soars 55 Medicis Pharmaceutical Corp 55 Genetic Defect 55 Alexza Pharmaceuticals ALXA 55 Sees 1Q Profit 55 Perscription 55 Eyetech Pharmaceuticals 55 3Q Profits 55 Ups Guidance 55 Pose Risks 55 Tops Ests 55 Feds Probing 55 Anticancer Agent 55 Amlodipine Besylate 55 Credit Raters 55 Cuts FY# EPS 55 Buyout Rumors 55 Brilique 55 Teva Copaxone 55 Test Detects 55 Posts 2Q Profit 55 SGXP 55 BRILINTA 55 Sector Wrap 55 Investor Relations section investor.biogenidec.comLiveTV LLC 55 Greenspan Warns 55 GenVec GNVC 55 Endometrial Cancer 55 Epoetin 55 Psivida 55 Vertex Pharmaceuticals VRTX 55 Biocryst 55 Antiviral Drugs 55 MNKD 55 Increases Buyback 55 LymphoStat B TM 55 Dyax DYAX 55 Reiterates FY# EPS 55 Q3 Profit Jumps 55 Questcor Pharmaceuticals QCOR 55 IIa Clinical Trial 55 Predict Risk 55 Clears Path 55 Inex Pharmaceuticals 55 Bayer HealthCare Onyx Pharmaceuticals 55 RSR# 55 UBS Maintains Neutral 55 Provides FY# EPS 55 Backs FY# Revenue 55 InNexus Biotechnology 55 Cheap Generic 55 Regulatory Filing 55 Antibiotic Use 55 CRYO 55 Sees Profits 55 Genentech Raptiva 55 Protease Inhibitor 55 Stocks Slip Ahead 55 Temsirolimus 55 Edwards Lifesciences EW 55 Boosts Forecast 55 Guidance Quick Facts 55 Posts 3Q Profit 55 Sycrest 55 Demonstrates Efficacy 55 Carotid Artery Stenting 55 Raises FY# EPS 55 Continues Slide 55 Patients Receiving 55 Inflammatory Disease 55 Profits Climb 55 Zoloft sertraline 55 Diuretic 55 Forecast Raised 55 Breast Cancer Treatment 55 Amid Slowdown 55 Study Casts Doubt 55 Neurobiological 55 Lower Than Expected 55 Novartis Galvus 55 Mulls Selling 55 Eszopiclone 55 MS ANTITRUST 55 Questions Loom 55 Pain Meds 55 Eye Infections 55 Oral Fingolimod 55 Drop Slightly 55 Kin Phones 55 PDUFA Prescription Drug 55 Profits Surge 55 Kos Pharma 55 Gene Mutations 55 Januvia sitagliptin 55 Bosentan 55 Nonprescription 55 Oncology Compounds 55 Lung Transplants 55 Posts 4Q Loss 55 Revises FY# EPS 55 Flu Vaccines 55 Systemic Delivery 55 Ercole Biotech 55 Warner Chilcott WCRX 55 Salix Pharmaceuticals Announces 55 Pivotal Study 55 Forecast Quick Facts 55 Acadia Pharmaceuticals 55 Q4 Adj 55 Beats Expectations 55 Anal Cancer